COP up +0.95% percent Today $COP High is at 71.09 and the

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
COP up +0.95% percent Today $COP High is at 71.09 and the Low 70.49 with current volume of 780,500.

Recent News posted below.

Conocophillips COP other info.
http://investorshangout.com/ConocoPhillips-COP-50593/

COP Conocophillips Recent Headline News

3 Buy-Rated Dividend Stocks Taking The Lead: COP, GEO, ARCC
at The Street - 1 hr 34 mins ago
These 3 dividend stocks are rated a Buy by TheStreet
ARCC: 16.35 (-0.01), GEO: 39.88 (+0.19), COP: 70.94 (+0.59)

Stock Market News for November 14, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - 2 hrs 55 mins ago
Benchmarks finished almost unchanged on Thursday as investors weighed upbeat corporate earnings results and deal news against another fall in energy shares
HAS: 54.83 (-0.15), HAL: 54.58 (+0.79), XOM: 94.75 (+0.09), COP: 70.94 (+0.59), WMT: 82.66 (-0.28), DWA: 26.16 (+0.64), SLB: 95.17 (+0.32), EOG: 97.42 (+1.57), TWC: 139.70 (-1.35), PG: 88.42 (-0.18), MSFT: 49.71 (+0.10), CVX: 115.95 (-0.50), CSCO: 26.19 (+0.51), BHI: 58.72 (-0.03)

ConocoPhillips Falls 1.19% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Nov 13, 3:52PM CST
ConocoPhillips (NYSE:COP) traded in a range yesterday that spanned from a low of $69.54 to a high of $71.00. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $71.07 on volume of 7.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
COP: 70.94 (+0.59)

ConocoPhillips (COP) Management Presents at Bank of America Merrill Lynch Global Energy Conference Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 13, 3:38PM CST

COP: 70.94 (+0.59)

U.S. crude tumbles below $75, oil stocks swirl lower
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 2:20PM CST

NBL: 55.09 (+1.10), XES: 34.37 (+0.15), BNO: 31.18 (+0.54), UGA: 46.77 (+0.68), CRUD: 34.40 (-0.05), SLB: 95.15 (+0.30), DO: 35.38 (+0.10), IXC: 40.80 (+0.23), ERY: 18.23 (-0.24), ERX: 78.72 (+0.23), FXN: 23.50 (+0.12), DNO: 40.54 (-0.37), UHN: 26.96 (+0.43), DDG: 24.49 (-0.20), DTO: 49.06 (-0.79), FILL: 23.88 (+0.09), HAL: 54.58 (+0.79), COP: 70.94 (+0.59), IEZ: 58.98 (+0.10), FENY: 24.78 (+0.12), PXE: 30.88 (+0.27), RDS.A: 69.10 (+0.69), GNAT: 18.73 (+0.16), CVX: 115.95 (-0.50), IEO: 79.24 (+0.76), DWTI: 51.20 (-0.93), OLO: 11.64 (+0.14), OIH: 43.77 (unch), XOP: 59.16 (+0.52), XOM: 94.75 (+0.09), DUG: 47.75 (-0.51), PXJ: 21.42 (+0.02), SDRL: 20.61 (-0.04), RIG: 25.97 (-0.32), OIL: 18.35 (+0.18), BP: 40.89 (+0.22), OLEM: 34.03 (-0.59), RYE: 75.77 (+0.34), XLE: 85.69 (+0.35), BHI: 58.72 (-0.03), VDE: 123.45 (+0.72), USO: 28.56 (+0.27), TWTI: 20.50 (unch), UCO: 20.86 (+0.32), DIG: 64.04 (+0.62), UWTI: 15.02 (+0.36), SCO: 42.84 (-0.77), IYE: 48.54 (+0.20), SZO: 44.57 (-0.77), TOT: 57.28 (+0.30), DBO: 22.48 (+0.20), IPW: 23.11 (+0.05), USL: 35.56 (+0.25)

Tracking Tweedy Browne Portfolio - Q3 2014 Update
John Vincent - at Seeking Alpha - Thu Nov 13, 10:14AM CST

MMM: 158.32 (-0.03), KOF: 101.33 (+0.72), LMT: 186.38 (-1.59), DNOW: 28.23 (+0.26), WMT: 82.67 (-0.27), CNQ: 35.61 (-0.12), GOOG: 543.80 (-1.58), DEO: 117.84 (-0.83), BSBR: 5.42 (-0.09), NOV: 70.92 (-0.60), JNJ: 108.41 (-0.66), GOOGL: 553.95 (-2.49), BK: 39.90 (+0.31), UNP: 120.61 (+0.36), CSCO: 26.18 (+0.50), MA: 84.22 (+0.02), JOY: 52.97 (+0.36), TMK: 53.16 (-0.12), PSX: 71.18 (+0.35), DVN: 63.73 (+0.45), AXP: 90.57 (-0.50), UN: 39.18 (-0.04), EMR: 63.70 (+0.18), HAL: 54.57 (+0.78), COP: 70.94 (+0.59), WFC: 53.51 (+0.12), UL: 40.73 (+0.03), ITW: 93.62 (+0.96), PM: 86.07 (-1.79), TOT: 57.28 (+0.30), BAX: 71.79 (-0.29), ANAT: 115.28 (+0.28), BRK.B: 145.94 (-0.35), VZ: 51.51 (+0.31), CMCSA: 53.88 (-0.42), BRK.A: 218,900.00 (-400.00), NVS: 94.08 (-0.30)

4 S&P 500 Dividend Dogs See 14.5% To 36% November Upsides
Fredrik Arnold - at Seeking Alpha - Thu Nov 13, 3:21AM CST

KMI: 39.11 (+0.73), FTR: 6.74 (+0.01), HCP: 43.52 (-0.40), ED: 62.15 (+0.15), FCX: 28.21 (+0.31), LO: 61.77 (-0.33), PCL: 40.55 (-0.23), COP: 70.94 (+0.59), WIN: 9.72 (-0.02), DRI: 56.05 (-0.25), T: 35.90 (+0.29), COH: 35.24 (+0.54), RIG: 25.97 (-0.32), ESV: 38.65 (-0.11), MAT: 30.98 (-0.19), VZ: 51.51 (+0.31), CTL: 40.70 (-0.22), NE: 20.90 (-0.22)

Exxon Mobil: A Buy Or A Sell Amid Lower Oil Prices?
Achilles Research - at Seeking Alpha - Thu Nov 13, 3:05AM CST

XOM: 94.76 (+0.10), COP: 70.95 (+0.60), CVX: 115.98 (-0.47)

Margin Of Safety: More Than Just Price
Eli Inkrot - at Seeking Alpha - Wed Nov 12, 11:34PM CST

KO: 42.71 (-0.08), JNJ: 108.41 (-0.66), GE: 26.48 (+0.06), XOM: 94.76 (+0.10), WMT: 82.67 (-0.27), COP: 70.95 (+0.60), BP: 40.88 (+0.21), CVX: 115.98 (-0.47)

U.S. shale producers talking tough in the face of lower oil prices
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 5:45PM CST

DVN: 63.72 (+0.44), CLR: 53.27 (+0.67), PXD: 167.59 (+2.42), EOG: 97.45 (+1.60), COP: 70.95 (+0.60), ROSE: 36.98 (+0.54)

Pioneer Natural Resources Goes Where Others Don’t in Tough Market
at The Street - Wed Nov 12, 11:00AM CST
Pioneer recently increased its capital expenditure guidance for this year and isn't showing any signs of slowing down as it aims for double-digit production growth, despite tumbling crude prices.
RDS.A: 69.10 (+0.69), PXD: 167.59 (+2.42), COP: 70.95 (+0.60)

What Happened If You Invested In Oil Stocks At The Peak?
Eli Inkrot - at Seeking Alpha - Wed Nov 12, 8:50AM CST

PSX: 71.18 (+0.35), COP: 70.95 (+0.60), XOM: 94.76 (+0.10), BP: 40.88 (+0.21), CVX: 115.98 (-0.47)

Production Begins From the Kebabangan Gas Development in Malaysia
Business Wire - Wed Nov 12, 8:00AM CST
ConocoPhillips (NYSE:COP) today announced the start of gas production from the Kebabangan (KBB) gas field, located approximately 60 miles offshore Malaysia. Production will ramp-up as pipeline capacity becomes available.
COP: 70.95 (+0.60)

Petronas, Shell, ConocoPhillips JV begins gas production off Malaysia
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 7:14AM CST

RDS.B: 72.37 (+0.56), RDS.A: 69.10 (+0.69), COP: 70.95 (+0.60)

Oando Energy Resources Announces Record Third Quarter Results
PR Newswire - Tue Nov 11, 7:56PM CST
Energy Resources Inc. ("OER" or the "Company" (TSX: OER), a company focused on oil and gas exploration and production in Nigeria, today announced financial and operating results for the three and nine month periods ended September 30, 2014. The unaudited financial statements, notes and management's discussion and analysis pertaining to the period are available on the System for Electronic Document Analysis and Retrieval ("SEDAR" at http://www.sedar.com and by visiting http://www.oandoenergyresources.com. All monetary figures reported herein are U.S dollars unless otherwise stated.
COP: 70.95 (+0.60), OER.TO: 1.80 (+0.13)

ConocoPhillips: Offshore Africa - The New Frontier?
Michael Fitzsimmons - at Seeking Alpha - Tue Nov 11, 3:05PM CST

HES: 82.34 (+1.24), COP: 70.95 (+0.60), MRO: 32.23 (+0.28)

Lower oil prices spark rise in energy bond activity
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 1:36PM CST

CJES: 19.81 (-0.07), FCX: 28.21 (+0.31), COP: 70.95 (+0.60), CVX: 115.98 (-0.47)

3 Dividend Machines I Accumulated Recently
Dividend Growth Investor - Seeking Alpha - Mon Nov 10, 9:11PM CST
I like accumulating things that provide me with something of value to me. Early in life, I accumulated knowledge and paid for it out of pocket by holding multiple part-time jobs, earned scholarships, and graduated with a couple of thousand in cash...
BAX: 71.79 (-0.29), EMR: 63.70 (+0.18), COP: 70.95 (+0.60), DEO: 117.84 (-0.83)

ConocoPhillips announces second oil discovery off Senegal
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 11:20AM CST

COP: 70.95 (+0.60)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles